Coinstar (NASDAQ:CSTR) missed on revenue expectations primarily due falling sales (- 9 percent) at Redbox to $458 million with DVD rental appearing to be down and this is a trend also seen at Netflix. Guidance was mostly as expected: Q3 revenue likely in the band $550M-$575M and EPS between $1.09-$1.24 as opposed to a consensus of $545M and $1.17. Full year revenue in the range $2.21B-$2.31B and EPS of $4.60-$4.90 against a consensus of $2.28B and $4.74.
Don’t Miss: Amazon Has BIG Plans for Kindle Fire.
Goldman Sachs raises Ford (NYSE:F) predicts better margins in the second half of 2012 and raises earning per share estimates for the next three years as enhanced capacity should help the firm increase market share with new products getting pricing muscle; commodities and hedging should also bolster earnings.
Human Genome Sciences (NASDAQ:HGSI) bares the fact that back in 2010 it spurned a $35 takeover bid from Amgen (NASDAQ:AMGN) in view of the imminent regulatory approval for its lupus drug Benlystsa. Human Genome was acquired by GlaxoSmithKline (NYSE:GSK) earlier this month for $14.25 per share.